GVR Report cover Capillary Blood Collection Devices Market Size, Share & Trends Report

Capillary Blood Collection Devices Market Size, Share & Trends Analysis Report By Material (Plastic, Glass, Stainless Steel), By Product, By End-use, By Application, By Region, And Segment Forecasts, 2025 - 2030

  • Report ID: GVR-2-68038-998-2
  • Number of Report Pages: 150
  • Format: PDF, Horizon Databook
  • Historical Range: 2018 - 2023
  • Forecast Period: 2025 - 2030 
  • Industry: Healthcare

Market Size & Trends

The global capillary blood collection devices market size was estimated at USD 2.13 billion in 2024 and is expected to grow at a CAGR of 8.8% from 2025 to 2030. Rising availability of PoC diagnostics, increasing prevalence of chronic diseases such as diabetes, cardiovascular diseases, and infectious diseases, and various advantages of the product, including frequent blood testing and monitoring, over its alternatives are some of the primary factors driving the market. In addition, the higher prevalence of anemia in developing countries is also driving the demand for capillary blood collection devices as they offer a convenient and accessible blood sampling method. As per World Health Organization estimates, 40% of children aged 6-59 months, 37% of pregnant women, and 30% of women aged 15-49 years globally are suffering from anemia.

Capillary Blood Collection Devices Market Size, by Product, 2020 - 2030 (USD Billion)

Over the past few decades, the prevalence of infectious and non-communicable diseases has significantly increased. Factors such as rapid urbanization, widespread poverty in many developing regions, the rise of antimicrobial resistance, and the growing incidence of foodborne illnesses have contributed to this trend. These dynamics are expected to drive market growth during the forecast period. According to the World Health Organization (WHO), non-communicable diseases, including chronic respiratory conditions, cardiovascular diseases, cancer, and diabetes, accounted for 74% of global deaths in 2022.

The field of Point-of-Care (PoC) diagnostics has experienced substantial growth in recent years, fueled by advancements in technologies such as biosensors, bioanalytical platforms, innovative assay designs, and other complementary research methodologies. U.S. data from the Population Reference Bureau highlights that the population aged 65 and above is likely to grow twice from 52 million in 2018 to over 94 million by 2060, which is expected to escalate the demand for PoC diagnostic solutions.

Innovations in molecular diagnostic tools have enabled faster and more cost-effective testing with enhanced convenience. Capillary blood collection devices support rapid hematology tests in conjunction with PoC diagnostics. Compared to venous or arterial blood collection, capillary sampling is less invasive, more affordable, and does not necessitate a trained professional for the procedure.

The growing adoption of rapid PoC diagnostic methods and capillary blood collection devices is predicted to increase further during the forecast period. These devices, when integrated with PoC diagnostic technologies, are particularly suitable for remote and ambulatory healthcare settings. Capillary sampling is frequently used for glucose and hemoglobin testing in clinics and hospitals due to its ease of use and minimally invasive nature. This makes it ideal for home-based testing, further driving market expansion.

The COVID-19 pandemic significantly influenced the capillary blood collection device market. The demand for these devices surged as they played a critical role in testing and monitoring COVID-19 cases, particularly in rapid antigen and antibody tests. Their ease of use and accessibility underscored the need for efficient diagnostic solutions, resulting in wider adoption.

Market Concentration & Characteristics

The degree of innovation in the capillary blood collection devices industry is significant, driven by advancements in materials, design, and functionality to improve patient comfort, accuracy, and usability. Recent innovations focus on creating minimally invasive devices that require smaller blood volumes while ensuring reliability in diagnostic testing. These devices integrate ergonomic designs for ease of use, particularly in point-of-care (POC) settings and home diagnostics, where user-friendly operation is critical.

There is high level of collaboration and partnership activities among stakeholders, including manufacturers, healthcare providers, research institutions, and technology developers. These collaborations are driven by the need to innovate and address market demands for more efficient, patient-friendly, and accurate solutions. Companies are increasingly partnering with research organizations to leverage advancements in microfluidics, biocompatible materials, and digital health integration.

Capillary Blood Collection Devices Industry Dynamics

Regulations significantly impact the capillary blood collection devices industry, shaping product development, manufacturing processes, and market entry strategies. Stringent regulatory requirements ensure that devices meet high standards of safety, efficacy, and quality, which is critical given their direct impact on patient health. Regulatory frameworks like the U.S. FDA’s 510(k) process or the EU’s In Vitro Diagnostic Regulation (IVDR) require extensive testing and documentation, including clinical performance evaluations and risk assessments, before a product can be commercialized.

Product expansion in the capillary blood collection devices industry is a critical growth strategy driven by evolving healthcare needs, advancements in diagnostic technologies, and increasing demand for minimally invasive solutions. Manufacturers are broadening their portfolios by introducing devices tailored for specific applications, such as neonatal care, geriatric patients, and point-of-care testing, where precision and patient comfort are paramount.

Regional expansion is a key growth strategy in the market for capillary blood collection devices, driven by the need to address varying healthcare demands, regulatory landscapes, and market dynamics across different geographies. In developed regions like North America and Europe, companies focus on leveraging advanced healthcare infrastructure and higher adoption rates of innovative diagnostic technologies. These markets prioritize high-precision devices for chronic disease management, such as diabetes monitoring and specialized applications like neonatal testing.

Material insights

The plastic segment accounted for the largest market share of 40.6 % in 2024. The widespread adoption of plastic-based devices can be attributed to their ease of use, disposability, and cost-effectiveness. Plastic materials are commonly employed in the production of various collection products due to their lightweight nature and biocompatibility with the human body. Over the last few decades, the use of plastic in medical device manufacturing has grown significantly. Key attributes such as safety, chemical stability, transparency, flexibility, and durability have driven its increasing utilization in healthcare applications. This segment is projected to retain its leading position throughout the forecast period.

The glass segment is likely to grow at a CAGR of 8.9% over the forecast period. Compared to plastic, glass offers the advantage of being easily recyclable, enhancing its environmental sustainability. This has led to a growing number of manufacturers focusing on producing glass-based medical products and devices. Glass is also highly resistant to heat, making it a preferred material for certain medical applications. Key attributes such as stability, precision, and resistance to microbial growth have contributed to its widespread adoption in the healthcare industry.

Ceramic materials are frequently used in the production of components like capillaries, connectors, and adapters. Their lightweight properties, exceptional heat resistance, and superior electrical insulation make them valuable in medical applications. Additionally, their mechanical strength is a critical factor driving their usage in healthcare. However, the high production costs and expensive nature of ceramics are expected to constrain the growth of this segment during the forecast period.

End-use Insights

The hospitals and clinics segment captured the highest market share of 29.6% in 2024. This trend is driven by the frequent need for diagnostic testing and the large patient influx in healthcare facilities. Meanwhile, the home care diagnosis segment is projected to achieve the highest compound annual growth rate (CAGR) of 10.1% during the forecast period, owing to the introduction of innovative devices designed for the convenient and effective diagnosis of conditions such as diabetes and anemia.

Data from the Centers for Disease Control and Prevention (CDC) indicates that approximately 125.7 million outpatient department visits occur annually in the United States. The growing number of surgical procedures, including angioplasty and kidney and liver transplants, combined with a rise in trauma-related injuries, has significantly increased the demand for blood transfusions in hospitals.

Blood donation centers typically operate independently, although some are integrated within hospitals and clinics. After collecting, blood undergoes processing and rigorous testing to detect disease-causing agents. It is then separated into various components based on specific requirements. Additionally, increased research and development (R&D) investments by major industry players to support the creation and launch of advanced products and devices are anticipated to further drive the growth of this segment.

Application Insights

The whole blood tests segment held the largest revenue share of 24.6% in 2024. Complete blood count (CBC) tests are the most commonly performed blood tests, used to measure components such as white blood cells (WBCs), red blood cells (RBCs), hemoglobin, hematocrit, and platelets. These tests offer essential insights to clinicians, helping detect abnormalities and enabling accurate diagnoses. They are also vital for monitoring chronic conditions such as diabetes and anemia. According to the CDC, diabetes is the eighth leading cause of death in the United States.

The increasing prevalence of infectious and chronic diseases, including cancer, anemia, autoimmune disorders, and diabetes, has driven higher demand for hematology tests, particularly whole blood tests. Additionally, plasma or protein tests are utilized to evaluate blood protein levels, offering clinicians a comprehensive view of a patient’s overall health. These tests, which analyze albumin and globulin levels, are commonly used to diagnose liver and kidney disorders, pancreatic disease, intestinal malabsorption, inflammation, nephrotic syndrome, and chronic liver conditions such as cirrhosis.

Capillary Blood Collection Devices Market Share, by Application, 2024 (%)

The plasma/ serum protein tests segment expected to grow at a CAGR of 9.3% by 2030. Plasma/serum protein tests are in demand due to their critical role in diagnosing and monitoring a wide range of health conditions. These tests provide essential information about the levels of proteins like albumin and globulin, which are key indicators of overall health. They are extensively used to detect and manage liver and kidney disorders, inflammation, autoimmune diseases, and nutritional deficiencies. Additionally, plasma/serum protein tests help identify conditions like nephrotic syndrome, chronic liver diseases such as cirrhosis, and pancreatic and intestinal malabsorption issues. Their ability to offer a comprehensive health profile makes them indispensable in clinical diagnostics, driving their growing utilization in healthcare settings.

Product Insights

The lancet accounted for the largest revenue share of 33.5% in 2024. The growing demand for lancets can be attributed to their frequent use in blood draw procedures, particularly for monitoring blood glucose levels in individuals with diabetes and collecting small blood samples for at-home testing. This segment is expected to maintain its dominance throughout the forecast period due to the consistent need for lancets in these applications. Lancets, which are small scalpels designed to puncture the skin and extract a blood sample, have become essential tools in managing diabetes and other conditions requiring regular blood testing. Additionally, the rising prevalence of infectious and chronic diseases has further driven the steady increase in lancet demand.

The micro-container tubes segment is likely to grow at a CAGR of 9.0% over the forecast period. These tubes are in demand due to their essential role in capillary blood collection, particularly in scenarios where only small volumes of blood are required. These tubes are widely used in diagnostic tests for infants, elderly patients, and individuals with conditions that make traditional venous blood collection challenging. Their compact design ensures precise sample handling and reduces the risk of contamination or wastage. Additionally, the growing adoption of point-of-care (PoC) diagnostics and at-home testing has further driven the demand for micro-container tubes, as they align perfectly with the need for minimally invasive, efficient, and convenient sample collection methods

Regional Insights

North America Capillary Blood Collection Devices Market Trends

The North America capillary blood collection devices market dominated and accounted for a 33.6% share in 2024. The growth is driven by a robust healthcare infrastructure and the presence of prominent clinical diagnostics companies. Additionally, the growing adoption of advanced technologies and an increased emphasis on clinical research are expected to support market expansion. According to CDC data, 6 out of 10 adults in the U.S. suffer from at least one chronic condition, while four out of ten have two or more. Factors such as the rising number of surgical interventions, increasing incidence of accidents and trauma, and the growing prevalence of both infectious and non-communicable diseases are anticipated to further fuel market growth in the region.

Capillary Blood Collection Devices Market Trends, by Region, 2025 - 2030

U.S. Capillary Blood Collection Devices Market Trends

The U.S. capillary blood collection devices market is projected to grow significantly during the forecast period. The increasing prevalence of chronic and infectious diseases, such as diabetes, anemia, and cardiovascular conditions, has driven the demand for minimally invasive and efficient diagnostic tools. Capillary blood collection devices are ideal for point-of-care (PoC) testing and home-based diagnostics, aligning with the growing preference for convenient and rapid healthcare solutions

Europe Capillary Blood Collection Devices Market Trends

The Europe capillary blood collection devices market is likely to emerge as a lucrative region, driven by increasing focus on point-of-care (PoC) testing and early disease detection. Moreover, the aging population in Europe, which often requires regular monitoring for chronic conditions, has contributed to the demand for these devices.

The UK capillary blood collection devices market is projected to grow during the forecast period. In the UK, the focus on preventive healthcare and early diagnosis has accelerated the adoption of these devices, as they facilitate frequent monitoring of conditions like diabetes. The National Health Service (NHS) has also supported the adoption of patient-friendly diagnostic tools to reduce hospital visits and promote self-management of chronic diseases.

The capillary blood collection devices market in France is expected to show steady growth over the forecast period, driven by France’s well-developed healthcare infrastructure and public health initiatives focusing on early diagnosis and disease management.

The Germany capillary blood collection devices market is projected to expand during the forecast period. The aging population in Germany, which requires continuous health monitoring, further drives the demand for these devices. In addition, technological advancements in diagnostic tools, combined with the country's strong regulatory support for medical innovations, are enhancing the adoption of capillary blood collection devices.

Asia Pacific Capillary Blood Collection Devices Market Trends

The Asia Pacific capillary blood collection devices market is expected to experience the highest growth rate of 10.0% CAGR during the forecast period owing to the increasing prevalence of chronic diseases such as diabetes, hypertension, and cardiovascular diseases. As many countries in the region face rising rates of diabetes and other non-communicable diseases, there is a growing need for cost-effective, minimally invasive diagnostic tools like capillary blood collection devices.

The China capillary blood collection devices market is projected to expand throughout the forecast period. Expanding healthcare infrastructure, coupled with a shift toward preventive care and early diagnosis, has further supported the adoption of these devices. As the healthcare system emphasizes managing chronic conditions outside of hospitals, there has been a strong push for point-of-care (PoC) testing and home-based diagnostics, both of which are facilitated by capillary blood collection devices

The capillary blood collection devices market in Japan is anticipated to grow during the forecast period. There is a growing awareness in Japan about the benefits of self-monitoring for chronic diseases, further driving the demand for capillary blood collection devices. As the Japanese healthcare system continues to focus on improving accessibility and reducing healthcare costs, the market for these devices is expected to expand. 

Latin America Capillary Blood Collection Devices Market Trends

The Latin America capillary blood collection devices industry is expected to experience significant growth throughout the forecast period. Healthcare infrastructure improvements in several countries, along with increasing access to medical services, have contributed to the adoption of these devices. In rural and underserved areas, where access to healthcare facilities may be limited, capillary blood collection devices provide a practical and affordable solution for disease monitoring.

The Brazil capillary blood collection devices market is anticipated to grow during the forecast period. Brazil's expanding healthcare infrastructure, along with growing government efforts to improve healthcare access in underserved areas, has further supported the use of these devices.

Middle East & Africa Capillary Blood Collection Devices Market Trends

The MEA capillary blood collection devices industry is anticipated to grow at a significant CAGR during the forecast period, owing to robust healthcare initiatives and rising disease prevalence. Saudi Arabia's Vision 2030 and the UAE Vision 2021, focusing on cancer and chronic disease management, are expected to boost demand for blood collection technologies. Increasing awareness and healthcare services, especially pertaining to chronic kidney disease in Kuwait, further drive market growth. Government-led preventive measures and healthcare expansions across the region highlight a positive outlook for the capillary blood collection market

The Saudi Arabia capillary blood collection devices market is anticipated to experience lucrative growth during the forecast period. Saudi Arabia's aging population, along with the government's initiatives to improve public health and reduce the burden of chronic diseases, further supports the adoption of these devices. There is also a growing awareness of the importance of preventive healthcare and self-management, particularly for chronic conditions such as diabetes, which drives the need for convenient, user-friendly testing options.

Key Capillary Blood Collection Devices Company Insights

The market is highly competitive, with numerous manufacturers holding significant market share. Key strategies such as product launches, regulatory approvals, strategic acquisitions, and innovations are employed by market players to enhance their presence and expand globally. For instance, in May 2022, Babson Diagnostics and BD announced the expansion of their strategic partnership, aimed at broadening their blood testing product portfolio and extending their global footprint.

Key Capillary Blood Collection Devices Companies:

The following are the leading companies in the capillary blood collection devices market. These companies collectively hold the largest market share and dictate industry trends.

View a comprehensive list of companies in the Capillary Blood Collection Devices Market

Recent Developments

  • In July 2024, O’Ryan.Health announced 2 pivotal studies namely The JDM Study and The Healthy Kids Study which involves at home pediatric blood collection with capillary collection devices from YourBio Health.

  • In December 2023, BD received U.S. FDA approval for its MiniDraw Capillary Blood Collection System. The device enables blood collection from fingertips for accurate laboratory results.

  • In July 2022, Rhinostics launched VERIstic Collection Device which enables capillary blood collection in less time. The device features an integrated cap which helps save time.

Capillary Blood Collection Devices Market Report Scope

Report Attribute

Details

Market size value in 2025

USD 2.31 billion

Revenue forecast in 2030

USD 3.52 billion

Growth rate

CAGR of 8.8% from 2025 to 2030

Base year for estimation

2024

Historical data

2018 - 2023

Forecast period

2025 - 2030

Quantitative units

Revenue in USD million/billion and CAGR from 2024 to 2030

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Product, material, end-use, application, region

Regional scope

North America; Europe; Asia Pacific; Latin America; MEA

Country scope

U.S.; Canada; Mexico; Germany; UK;, France; Spain; Italy; Denmark; Sweden; Norway; China; Japan; India; South Korea; Australia; Thailand; Brazil; Argentina; Saudi Arabia; Kuwait; UAE; South Africa

Key companies profiled

Becton, Dickinson and Company (BD); Greiner Bio-One International GmbH; SARSTEDT AG & Co. KG; Terumo Medical Corp.; B. Braun Melsungen AG; Improve Medical; Abbott Laboratories; Cardinal Health

Customization scope

Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope.

Global Capillary Blood Collection Devices Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the capillary blood collection devices market report based on product, material, end-use, application, and region:

  • Product Outlook (Revenue, USD Million, 2018 - 2030)

    • Lancets

    • Micro-container Tubes

    • Micro-hematocrit Tubes

    • Warming Devices

    • Others

  • Material Outlook (Revenue, USD Million, 2018 - 2030)

    • Plastic

    • Glass

    • Stainless Steel

    • Ceramic

    • Others

  • End-use Outlook (Revenue, USD Million, 2018 - 2030)

    • Hospitals and Clinics

    • Blood Donation Centers

    • Diagnostic Centers

    • Home Diagnosis

    • Pathology Laboratories

  • Application Outlook (Revenue, USD Million, 2018 - 2030)

    • Whole Blood

    • Plasma/ Serum Protein Tests

    • Comprehensive Metabolic Panel (CMP) Tests

    • Liver Panel / Liver Profile/ Liver Function Tests

    • Dried Blood Spot Tests

  • Regional Outlook (Revenue, USD Million, 2018 - 2030)

    • North America

      • U.S.

      • Canada

      • Mexico

    • Europe

      • Germany

      • UK

      • France

      • Italy

      • Spain

      • Norway

      • Sweden

      • Denmark

    • Asia Pacific

      • Japan

      • China

      • India

      • Australia

      • Singapore

      • South Korea

      • Thailand

    • Latin America

      • Brazil

      • Argentina

    • Middle East & Africa

      • South Africa

      • Saudi Arabia

      • UAE

      • Kuwait

Frequently Asked Questions About This Report

pdf icn

GET A FREE SAMPLE

arrow icn

This FREE sample includes data points, ranging from trend analyses to estimates and forecasts. See for yourself.

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now

Certified Icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.